Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Saeed, Sahar"" wg kryterium: Autor


Tytuł:
Switch to a raltegravir-based antiretroviral regimen in people with HIV and non-alcoholic fatty liver disease: A randomized controlled trial.
Autorzy:
Shengir M; Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
Lebouche B; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Elgretli W; Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
Saeed S; Queen's University, Kingston, Ontario, Canada.
Ramanakumar AV; Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.
Giannakis A; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
De Pokomandy A; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Cox J; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Costiniuk C; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Routy JP; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Klein MB; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Sebastiani G; Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Pokaż więcej
Źródło:
HIV medicine [HIV Med] 2024 Jan; Vol. 25 (1), pp. 135-142. Date of Electronic Publication: 2023 Aug 28.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase IV; Journal Article
MeSH Terms:
HIV Infections*/complications
HIV Infections*/drug therapy
Non-alcoholic Fatty Liver Disease*/drug therapy
Male ; Humans ; Middle Aged ; Female ; Raltegravir Potassium/therapeutic use ; Keratin-18 ; Anti-Retroviral Agents/therapeutic use ; Lipids ; Aspartate Aminotransferases
Czasopismo naukowe
Tytuł:
Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort.
Autorzy:
Cinque F; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.
Saeed S; Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
Kablawi D; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.
Ramos Ballesteros L; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.
Elgretli W; Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
Moodie EEM; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
Price C; Canadian HIV/AIDS and Chronic Pain Society, Ottawa, Ontario, Canada.
Monteith K; COCQ SIDA, Montreal, Quebec, Canada.
Cooper C; Department of Medicine, Division of Infectious Diseases, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Walmsley SL; Department of Medicine, Division of Infectious Diseases, University of Toronto, Toronto, Ontario, Canada.
Pick N; Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
Murray MCM; Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
Cox J; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
Kronfli N; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Costiniuk CT; Chronic Viral Illness Service, McGill University, Montreal, Quebec, Canada.
de Pokomandy A; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Routy JP; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Lebouché B; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.; Department of Family Medicine, McGill University Faculty of Medicine and Health Sciences, Montreal, Quebec, Canada.
Klein MB; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
Sebastiani G; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada .; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.; Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2023 Aug 22; Vol. 13 (8), pp. e076547. Date of Electronic Publication: 2023 Aug 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Liver Diseases*/epidemiology
Liver Diseases*/etiology
Fatty Liver*
HIV Infections*/complications
HIV Infections*/epidemiology
Humans ; Prospective Studies ; Quality of Life ; Canada/epidemiology ; Observational Studies as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Tytuł:
Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patients.
Autorzy:
Benmassaoud A; McGill University Health Centre, Montreal, Quebec, Canada.
Macias J; Hospital Universitario de Valme, Seville, Spain.
Delamarre A; Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Corma-Gomez A; Hospital Universitario de Valme, Seville, Spain.
Guaraldi G; University of Modena and Reggio Emilia, Modena, Italy.
Milic J; University of Modena and Reggio Emilia, Modena, Italy.
Rockstroh JK; Bonn University Hospital, Bonn, Germany.; German Centre for Infection Research (DZIF), partner site Cologne-Bonn, Bonn, Germany.
Van Bremen K; Bonn University Hospital, Bonn, Germany.; German Centre for Infection Research (DZIF), partner site Cologne-Bonn, Bonn, Germany.
Tsochatzis E; Royal Free London NHS Foundation Trust, London, UK.
Mulay A; Royal Free London NHS Foundation Trust, London, UK.
Price J; University of California San Francisco, San Francisco, California, USA.
Garvey LJ; Imperial College Healthcare NHS Trust, London, UK.
Lemoine M; Imperial College Healthcare NHS Trust, London, UK.
Kablawi D; McGill University Health Centre, Montreal, Quebec, Canada.
Lebouche B; McGill University Health Centre, Montreal, Quebec, Canada.
Klein MB; McGill University Health Centre, Montreal, Quebec, Canada.
Ballesteros LR; McGill University Health Centre, Montreal, Quebec, Canada.
Boesecke C; Bonn University Hospital, Bonn, Germany.; German Centre for Infection Research (DZIF), partner site Cologne-Bonn, Bonn, Germany.
Schepis F; University of Modena and Reggio Emilia, Modena, Italy.
Bhagani S; Royal Free London NHS Foundation Trust, London, UK.
Cooke G; Imperial College Healthcare NHS Trust, London, UK.
Berzigotti A; Bern University Hospital, Bern, Switzerland.
Hirose K; University of California San Francisco, San Francisco, California, USA.
Pineda JA; Hospital Universitario de Valme, Seville, Spain.
Ramanakumar AV; Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.
De-Ledinghen V; Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Saeed S; Queen's University, Kingston, Ontario, Canada.
Sebastiani G; McGill University Health Centre, Montreal, Quebec, Canada.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2023 Jul; Vol. 43 (7), pp. 1427-1439. Date of Electronic Publication: 2023 May 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hypertension, Portal*/complications
HIV Infections*/complications
Elasticity Imaging Techniques*
Humans ; Liver Cirrhosis ; Prognosis ; Spleen/diagnostic imaging ; Blood Platelets ; Liver/diagnostic imaging ; Liver/pathology
Czasopismo naukowe
Tytuł:
Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
Autorzy:
Lanièce Delaunay C; Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, Faculty of Medicine, McGill University, 1020 Avenue des Pins Ouest, H3A 1A2, Montreal QC, Canada; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, 5252 Boulevard de Maisonneuve Ouest, H4A 3S5, Montreal QC, Canada.
Maheu-Giroux M; Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, Faculty of Medicine, McGill University, 1020 Avenue des Pins Ouest, H3A 1A2, Montreal QC, Canada.
Marathe G; Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, Faculty of Medicine, McGill University, 1020 Avenue des Pins Ouest, H3A 1A2, Montreal QC, Canada; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, 5252 Boulevard de Maisonneuve Ouest, H4A 3S5, Montreal QC, Canada.
Saeed S; Institute for Public Health, Washington University, 600 S Taylor Avenue, St. Louis, MO 63110, United States of America.
Martel-Laferrière V; Département de Médecine Spécialisée et de Médecine des Laboratoires, Centre Hospitalier de L'Université de Montréal, 264 Boulevard René-Lévesque Est, H2×1P1, Montreal QC, Canada; Centre de Recherche du Centre Hospitalier de L'Université de Montréal, 900 Rue Saint-Denis, H2×0A9, Montreal QC, Canada; Département de Microbiologie, Maladies Infectieuses, et Immunologie, Université de Montréal, 2900 Boulevard Édouard-Monpetit, H3T 1J4, Montreal QC, Canada.
Cooper CL; Division of Infectious Diseases, Department of Medicine, Ottawa Hospital Research Institute, 725 Parkdale Avenue, K1Y 4E9, Ottawa ON, Canada.
Walmsley S; Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, University of Toronto, 6 Queen's Park Crescent West, M5S 3H2, Toronto ON, Canada; University Health Network, University of Toronto, 190 Elizabeth Street, M5G 2C4, Toronto ON, Canada.
Cox J; Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, Faculty of Medicine, McGill University, 1020 Avenue des Pins Ouest, H3A 1A2, Montreal QC, Canada; Department of Medicine, Division of Infectious Disease and Chronic Viral Illness Service, McGill University Health Centre, 1001 Boulevard Décarie, H4A 3J1, Montreal QC, Canada.
Wong A; Division of Infectious Diseases, Department of Medicine, University of Saskatchewan, 107 Wiggins Road, S7N 5E5, Saskatoon SK, Canada.
Klein MB; Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, Faculty of Medicine, McGill University, 1020 Avenue des Pins Ouest, H3A 1A2, Montreal QC, Canada; Department of Medicine, Division of Infectious Disease and Chronic Viral Illness Service, McGill University Health Centre, 1001 Boulevard Décarie, H4A 3J1, Montreal QC, Canada; Canadian HIV Trials Network, Canadian Institutes of Health Research, 588-1081 Burrard Street, V6Z 1Y6, Vancouver BC, Canada. Electronic address: .
Pokaż więcej
Corporate Authors:
Canadian Coinfection Cohort investigators
Źródło:
The International journal on drug policy [Int J Drug Policy] 2022 May; Vol. 103, pp. 103627. Date of Electronic Publication: 2022 Feb 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Coinfection*/drug therapy
Drug Users*
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Hepatitis C*/complications
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Hepatitis C, Chronic*/drug therapy
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/drug therapy
Substance Abuse, Intravenous*/epidemiology
Adult ; Analgesics, Opioid/therapeutic use ; Antiviral Agents/therapeutic use ; British Columbia/epidemiology ; Cohort Studies ; Female ; Hepacivirus ; Humans ; Male
Czasopismo naukowe
Tytuł:
Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review.
Autorzy:
Saeed S; Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada.
Uzicanin S; Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada.
Lewin A; Surveillance and Biological Risk Assessment, Héma-Québec, Montreal, Québec, Canada.
Lieshout-Krikke R; Department of Medical Affairs, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands.
Faddy H; School of Health and Behavioural Sciences, University of the Sunshine Coast, Petrie, Queensland, Australia.
Erikstrup C; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Osiowy C; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Seed CR; Donor and Product Safety Policy Unit, Australian Red Cross Lifeblood, Perth, Western Australia, Australia.
Steele WR; Epidemiology and Surveillance Group, Scientific Affairs, American Red Cross, Rockville, Maryland, USA.
Davison K; NHS Blood and Transplant/Public Health England Epidemiology Unit, London, UK.
Custer B; Research and Scientific Programs, Vitalant, San Francisco, California, USA.
O'Brien SF; Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada.
Pokaż więcej
Corporate Authors:
Surveillance Risk Assessment and Policy (SRAP) Sub-group of the Transfusion Transmitted Infectious Diseases Working Party of the International Society of Blood Transfusion
Źródło:
Vox sanguinis [Vox Sang] 2022 Apr; Vol. 117 (4), pp. 476-487. Date of Electronic Publication: 2021 Dec 03.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*/epidemiology
SARS-CoV-2*
Antibodies, Viral ; Blood Donors ; Humans ; Seroepidemiologic Studies
Czasopismo naukowe
Tytuł:
Two-Tier Care Pathways for Liver Fibrosis Associated to Non-Alcoholic Fatty Liver Disease in HIV Mono-Infected Patients.
Autorzy:
Sebastiani G; Chronic Viral Illness Service, McGill University Health Centre, Montréal, QC H4A 3J1, Canada.; Division of Gastroenterology and Hepatology, Royal Victoria Hospital, McGill University Health Centre, Montréal, QC H4A 3J1, Canada.; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, QC H4A 3J1, Canada.
Milic J; Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, 41121 Modena, Italy.; Department of Infectious Diseases, Azienda Ospedaliero-Universitaria di Modena, 41124 Modena, Italy.
Cervo A; Chronic Viral Illness Service, McGill University Health Centre, Montréal, QC H4A 3J1, Canada.; Department of Infectious Diseases, Azienda Ospedaliero-Universitaria di Modena, 41124 Modena, Italy.
Saeed S; Department of Internal Medicine-Infectious Disease, Center for Dissemination and Implementation, Institute for Public Health, School of Medicine, Washington University, St. Louis, MO 63110-1010, USA.
Krahn T; Chronic Viral Illness Service, McGill University Health Centre, Montréal, QC H4A 3J1, Canada.
Kablawi D; Division of Gastroenterology and Hepatology, Royal Victoria Hospital, McGill University Health Centre, Montréal, QC H4A 3J1, Canada.
Al Hinai AS; Division of Experimental Medicine, McGill University, Montréal, QC H4A 3J1, Canada.
Lebouché B; Chronic Viral Illness Service, McGill University Health Centre, Montréal, QC H4A 3J1, Canada.; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, QC H4A 3J1, Canada.; Department of Family Medicine, McGill University, Montréal, QC H3S 1Z1, Canada.
Wong P; Division of Gastroenterology and Hepatology, Royal Victoria Hospital, McGill University Health Centre, Montréal, QC H4A 3J1, Canada.
Deschenes M; Division of Gastroenterology and Hepatology, Royal Victoria Hospital, McGill University Health Centre, Montréal, QC H4A 3J1, Canada.
Gioè C; Infectious and Tropical Disease Unit, AOU Policlinico 'P. Giaccone', 90127 Palermo, Italy.
Cascio A; Infectious and Tropical Disease Unit, AOU Policlinico 'P. Giaccone', 90127 Palermo, Italy.; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties-University of Palermo, 90127 Palermo, Italy.
Mazzola G; Infectious Diseases Unit, S. Elia Hospital, 93100 Caltanissetta, Italy.
Guaraldi G; Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, 41121 Modena, Italy.; Department of Infectious Diseases, Azienda Ospedaliero-Universitaria di Modena, 41124 Modena, Italy.
Pokaż więcej
Źródło:
Journal of personalized medicine [J Pers Med] 2022 Feb 15; Vol. 12 (2). Date of Electronic Publication: 2022 Feb 15.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Appraising clinical applicability of studies: mapping and synthesis of current frameworks, and proposal of the FrACAS framework and VICORT checklist
Autorzy:
Nguyen, Quoc DinhAff1, Aff2, Aff3, IDs12874021014450_cor1
Moodie, Erica M.
Desmarais, PhilippeAff1, Aff2
Goulden, RobertAff3, Aff4
Forget, Marie-France
Peters, Eric
Saeed, Sahar
Keezer, Mark R.Aff2, Aff7
Wolfson, ChristinaAff3, Aff4, Aff8
Pokaż więcej
Źródło:
BMC Medical Research Methodology. 21(1)
Czasopismo naukowe
Tytuł:
An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers.
Autorzy:
Lewin A; Medical Affairs & Innovation, Héma-Québec, Montreal, QC, Canada.
Drews SJ; Microbiology, Canadian Blood Services, Edmonton, AB, Canada.
Lieshout-Krikke R; Department of Medical Affairs, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.
Erikstrup C; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Saeed S; Epidemiology & Surveillance, Canadian Blood Services, Ottawa, ON, Canada.
Fady H; School of Health and Behavioural Sciences, University of the Sunshine Coast, Petrie, QLD, Australia.
Uzicanin S; Epidemiology & Surveillance, Canadian Blood Services, Ottawa, ON, Canada.
Custer B; Research & Scientific Programs, Vitalant, San Francisco, CA, USA.
O'Brien SF; Epidemiology & Surveillance, Canadian Blood Services, Ottawa, ON, Canada.
Pokaż więcej
Corporate Authors:
Surveillance, Risk Assessment, Policy, the Virology Sub-groups of the ISBT Transfusion Transmitted Infectious Diseases Working Party
Źródło:
Vox sanguinis [Vox Sang] 2021 Oct; Vol. 116 (9), pp. 946-954. Date of Electronic Publication: 2021 Apr 29.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
SARS-CoV-2*
Adult ; Antibodies, Viral ; Humans ; Pandemics ; Sensitivity and Specificity ; Seroepidemiologic Studies ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard.
Autorzy:
Saeed S; Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Canada.
O'Brien SF; Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
Abe K; Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health System, Toronto, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Canada.
Yi QL; Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
Rathod B; Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health System, Toronto, Canada.
Wang J; Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health System, Toronto, Canada.
Fazel-Zarandi M; Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health System, Toronto, Canada.
Tuite A; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Fisman D; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Wood H; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
Colwill K; Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health System, Toronto, Canada.
Gingras AC; Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health System, Toronto, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Canada.
Drews SJ; Microbiology Department, Canadian Blood Services, Ottawa, Canada.; Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine & Pathology, University of Alberta, Edmonton, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Sep 23; Vol. 16 (9), pp. e0257743. Date of Electronic Publication: 2021 Sep 23 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19/*immunology
SARS-CoV-2/*immunology
Adult ; Aged ; Antibodies, Viral/immunology ; Bayes Theorem ; Blood Donors ; Canada ; Cross-Sectional Studies ; Female ; Humans ; Immunoglobulin G/immunology ; Male ; Middle Aged ; Nucleocapsid/immunology ; Pandemics/prevention & control ; Sensitivity and Specificity ; Seroepidemiologic Studies ; Spike Glycoprotein, Coronavirus/immunology ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies